Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

21.10
Delayed Data
As of Jan 18
 +0.60 / +2.93%
Today’s Change
16.40
Today|||52-Week Range
40.57
+12.23%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Cohen Ronald
President & Chief Executive Officer
Sale12/14/201639,764$20.75$825.1K+1.93%
Cohen Ronald
President & Chief Executive Officer
Buy12/14/201640,172$15.49$622.3K+1.93%
Blight Andrew R
Chief Scientific Officer
Buy8/09/20169,754$22.13$215.9K-12.05%
Blank Burkhard
Chief Medical Officer
Sale12/01/201610,000$20.74$207.4K+4.20%
Wasman Jane
President-International & General Counsel
Buy6/10/20168,647$22.13$191.4K-22.05%
Cohen Ronald
President & Chief Executive Officer
Buy2/04/201610,591$15.49$164.1K-43.40%
Cohen Ronald
President & Chief Executive Officer
Sale12/01/20167,160$20.74$148.5K+4.20%
Hindman Andrew Asa
Chief Business Development Officer
Sale5/13/20164,860$26.11$126.9K-20.11%
Blight Andrew R
Chief Scientific Officer
Sale12/01/20164,855$20.76$100.8K+4.20%
Lawrence David /acorda/
Sale12/01/20164,416$20.74$91.6K+4.20%
Page of 4